Breaking News, Collaborations & Alliances

Argenta in Respiratory Pact with Pulmagen

Two-year deal covers development services for two candidates

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Argenta has signed a subcontracting agreement with Pulmagen Therapeutics to perform integrated services on two respiratory projects. Argenta will be eligible to receive as much as $10 million in fee-for-service payments over two years, with the possibility of extensions, to perform chemistry, biology, ADMET/PK and pharmacology services to bring two respiratory projects to preclinical status. “We are pleased that Pulmagen has come to Argenta for two projects of such substantial scope. The...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters